Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,019 | -24,884 | -10,263 | -15,164 | -45,189 |
| Depreciation Amortization | 1,189 | 925 | 580 | 155 | 766 |
| Accounts receivable | 3,247 | 1,995 | 5,194 | 3,896 | -7,375 |
| Other Working Capital | 18,445 | 17,105 | 17,789 | 9,488 | 1,155 |
| Other Operating Activity | 7,022 | 6,571 | 1,072 | -2,101 | 12,092 |
| Operating Cash Flow | $-13,116 | $1,712 | $14,372 | $-3,726 | $-38,551 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -11,420 | -12,469 | 5,477 | -896 | -39,875 |
| PPE Investments | -5,122 | -1,076 | -934 | -565 | -106 |
| Other Investing Activity | -1,462 | -1,472 | -1,419 | -2,487 | 1 |
| Investing Cash Flow | $-18,004 | $-15,017 | $3,124 | $-3,948 | $-39,980 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,479 | 5,392 | 4,745 | 1,501 | 111,907 |
| Financing Cash Flow | $5,479 | $5,392 | $4,745 | $1,501 | $111,907 |
| Beginning Cash Position | 54,540 | 54,540 | 54,540 | 54,540 | 21,164 |
| End Cash Position | 28,899 | 46,627 | 76,781 | 48,367 | 54,540 |
| Net Cash Flow | $-25,641 | $-7,913 | $22,241 | $-6,173 | $33,376 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,116 | 1,712 | 14,372 | -3,726 | -38,551 |
| Capital Expenditure | -5,122 | -1,076 | -934 | -565 | -106 |
| Free Cash Flow | -18,238 | 636 | 13,438 | -4,291 | -38,657 |